183 Antiplatelet and Anticoagulation Use and Outcomes Following Chronic Subdural Hematoma Drainage: Systematic Review and Meta-Analysis

View at publisher Summarise with VIRAT
Authors: Eva Liu, Natalie Tilbury, Tye Morin, Amy Zhou, Jack M. F. Su, Amit R L Persad, Julia A. E. Radic
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

INTRODUCTION: Chronic subdural hematoma (CSDH) is a common neurosurgical condition which can be treated with surgical evacuation. A significant percentage of CSDH patients are on antiplatelet or anticoagulation therapy at baseline. METHODS: A search was conducted in MEDLINE (1946 to Feb 6, 2025), Embase (1974 to Feb 6, 2025), and PubMed (up to Feb 7, 2025) on preoperative use of antiplatelet or anticoagulation therapy and outcomes following surgical evacuation of CSDH. We followed the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines to systematically screen studies. RESULTS: Our literature search identified 3227 studies, out of which 47 were included. There were 16,288 patients included for analysis, with 3486 (21%) in the antiplatelet (AP) group, 2230(14%) in the anticoagulation (AC) group, and 10,715 (66%) in the no antithrombotics (NA) group. the weighted mean age of the included patients was 74.2 years and 29.4% were female. the AP group had similar recurrence compared to NA (RR = 1.141, 95% CI = 0.93 to 1.40, p = 0.22). the AC group however had significantly high recurrence compared to NA (RR 1.42,. 95% CI = 1.14 to 1.77, p = 0.002). However, being on any antithrombotic therapy is also associated with significantly higher thromboembolic events (RR 4.91, 95% CI 2.65 to 9.10, p < 0.00001). CONCLUSIONS: Patients on antithrombotic therapy have both higher recurrence and thromboembolic risk compared to patients not on antithrombotic therapy. Clinicians need to weigh the risk of recurrence against thromboembolism when deciding when to hold and resume antithrombotic therapy for patients undergoing evacuation of CSDH.

Fields of Study & Subjects

Neurosurgical Procedures and Complications Spinal Hematomas and Complications Intracerebral and Subarachnoid Hemorrhage Research

Publication details

Journal / source
Neurosurgery
Volume
72
Issue
Supplement_1
Pages
36–37
Publication date
26 March 2026
Language
EN